Global Health Innovative Technology Fund (GHIT Fund)
The Global Health Innovative Technology Fund (GHIT Fund) is an international public-private partnership between the Government of Japan, multiple pharmaceutical companies, the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme (UNDP). It facilitates global R&D partnerships for the discovery and development of new health technologies for the developing world and invests in these global R&D partnerships through a grant-making mechanism. Its portfolio covers drugs, vaccines, and diagnostics in infectious diseases, such as HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases.
GHIT Fund publishes calls for proposals under four platforms:
- Target Research Platform
- Drug Discovery Screening Platform
- Hit-to-Lead Platform and
- Product Development Platform
Further information on GHIT’s platforms is available here.
Please see below for more information about open opportunities.
10:00 am (JST) on July 14, 2023
Please refer to the GHIT Investment Opportunity schedule for the anticipated future call for proposals relating to the Target Research, Drug Discovery Screening, Hit-to-Lead and Product Development Platforms.
To be indicated by the applicant.
For further information about the GHIT Fund RFP Screening Platform 2023-001, click here. Please note that questions specific to GHIT Fund RFP Screening Platform 2023-001 can only be answered with the submission of the GHIT RFP Screening Platform 2023-001 Contact Form.